Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 100101-100150 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03120312
Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement
N/A
Recruiting
1,500 participants
Started: Oct 30, 2020 · Completed: Jan 31, 2024
1 condition
1 sponsor
1 location
NCT04446962
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
PHASE1/PHASE2
Active, not recruiting
118 participants
Started: Oct 30, 2020 · Completed: Aug 30, 2035
2 conditions
2 sponsors
28 locations
NCT04624308
Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC
PHASE2
Not yet recruiting
81 participants
Started: Oct 30, 2020 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT04540211
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
PHASE3
Active, not recruiting
461 participants
Started: Oct 30, 2020 · Completed: Jan 31, 2026
1 condition
1 sponsor
67 locations
NCT04592289
Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone
NA
Recruiting
622 participants
Started: Oct 30, 2020 · Completed: Aug 31, 2024
1 condition
1 sponsor
7 locations
NCT05557617
Periodontitis and Periodontal Bacteria in Dementia
N/A
Active, not recruiting
120 participants
Started: Oct 30, 2020 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT04417621
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
PHASE2
Active, not recruiting
134 participants
Started: Oct 30, 2020 · Completed: Mar 27, 2026
1 condition
1 sponsor
36 locations
NCT04451278
RESting-state Functional MRI for Prediction of Post-surgical Prognosis In Pediatric Drug-Resistant Epilepsy
N/A
Recruiting
200 participants
Started: Oct 30, 2020 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT04487041
Tfh Dysfunction in HIV and Aging
PHASE4
Recruiting
400 participants
Started: Oct 30, 2020 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT04469231
The Synergy Disc To Anterior Cervical Discectomy and Fusion
NA
Active, not recruiting
175 participants
Started: Oct 30, 2020 · Completed: Jan 1, 2026
1 condition
2 sponsors
19 locations
NCT05479929
Work of Breathing Assessment in Triage Scale
N/A
Active, not recruiting
39 participants
Started: Oct 30, 2020 · Completed: Oct 31, 2025
5 conditions
1 sponsor
1 location
NCT06242171
Prognostic Indices of Atheromatosis Severity and Coronary Artery Bypass Surgery Outcomes for Patients With Coronary Artery Disease
N/A
Active, not recruiting
90 participants
Started: Oct 30, 2020 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT04066192
Brexpiprazole in Alcohol Use Disorder
PHASE2
Recruiting
250 participants
Started: Oct 30, 2020 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT04358276
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
NA
Active, not recruiting
840 participants
Started: Oct 30, 2020 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT04579588
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
N/A
Recruiting
230 participants
Started: Oct 29, 2020 · Completed: Mar 31, 2026
3 conditions
2 sponsors
1 location
NCT04541680
Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis
PHASE3
Recruiting
250 participants
Started: Oct 29, 2020 · Completed: Jul 31, 2024
1 condition
2 sponsors
1 location
NCT04614922
Acceptance and Commitment Therapy-based Rehabilitation of Post-concussion Symptoms
NA
Recruiting
48 participants
Started: Oct 29, 2020 · Completed: Nov 30, 2026
2 conditions
2 sponsors
1 location
NCT04528680
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PHASE1/PHASE2
Active, not recruiting
57 participants
Started: Oct 29, 2020 · Completed: Nov 30, 2025
6 conditions
4 sponsors
1 location
NCT04603625
Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy
NA
Active, not recruiting
72 participants
Started: Oct 29, 2020 · Completed: Dec 31, 2025
1 condition
10 sponsors
1 location
NCT04467021
Cancer and Blood Pressure Management, CARISMA Study
NA
Active, not recruiting
61 participants
Started: Oct 29, 2020 · Completed: Aug 31, 2026
9 conditions
2 sponsors
25 locations
NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PHASE1/PHASE2
Recruiting
230 participants
Started: Oct 29, 2020 · Completed: Jul 14, 2026
30 conditions
2 sponsors
82 locations
NCT04505579
The Tether™ - Vertebral Body Tethering System Post Approval Study
N/A
Recruiting
200 participants
Started: Oct 29, 2020 · Completed: Dec 31, 2027
1 condition
3 sponsors
10 locations
NCT04601363
Personalized Spine Study Group (PSSG) Registry
N/A
Recruiting
1,000 participants
Started: Oct 29, 2020 · Completed: Apr 30, 2030
7 conditions
2 sponsors
1 location
NCT04873011
Effect of Quinine Hydrochloride in Overweight Population on Food Intake, Hunger and Gut Peptide Release
PHASE1
Recruiting
40 participants
Started: Oct 29, 2020 · Completed: Oct 29, 2025
1 condition
1 sponsor
1 location
NCT05101382
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
N/A
Recruiting
500 participants
Started: Oct 28, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
13 locations
NCT04405583
The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients
N/A
Recruiting
150 participants
Started: Oct 28, 2020 · Completed: Oct 31, 2027
1 condition
1 sponsor
14 locations
NCT04501718
Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
PHASE2
Recruiting
44 participants
Started: Oct 28, 2020 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT04918082
Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
N/A
Active, not recruiting
133 participants
Started: Oct 28, 2020 · Completed: Jun 28, 2026
3 conditions
1 sponsor
1 location
NCT04582279
Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients
NA
Recruiting
90 participants
Started: Oct 28, 2020 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT04612309
Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer
N/A
Active, not recruiting
100 participants
Started: Oct 28, 2020 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT04408313
Extended Release Naltrexone Versus Extended Release Buprenorphine with Individuals Leaving Jail
PHASE2/PHASE3
Active, not recruiting
240 participants
Started: Oct 28, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04206969
Assessment of Transcultural Psychotherapy in Child Major Depressive Disorder
NA
Active, not recruiting
80 participants
Started: Oct 28, 2020 · Completed: May 31, 2025
1 condition
2 sponsors
4 locations
NCT04324112
Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL
PHASE2
Recruiting
45 participants
Started: Oct 28, 2020 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT04567303
Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration
PHASE1/PHASE2
Recruiting
251 participants
Started: Oct 28, 2020 · Completed: Dec 30, 2028
1 condition
1 sponsor
53 locations
NCT07204327
Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001)
N/A
Active, not recruiting
1,136 participants
Started: Oct 28, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04361370
Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer
PHASE2
Enrolling by invitation
44 participants
Started: Oct 28, 2020 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT04250493
Insulin Resistance in Multiple System Atrophy
NA
Recruiting
124 participants
Started: Oct 28, 2020 · Completed: Oct 28, 2027
1 condition
4 sponsors
1 location
NCT06701214
The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
N/A
Recruiting
800 participants
Started: Oct 28, 2020 · Completed: Nov 30, 2031
1 condition
1 sponsor
1 location
NCT04595565
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
PHASE3
Active, not recruiting
1,332 participants
Started: Oct 28, 2020 · Completed: Mar 30, 2029
2 conditions
7 sponsors
163 locations
NCT04827433
Mode of Delivery in Women With Low-lying Placenta
N/A
Recruiting
2,550 participants
Started: Oct 28, 2020 · Completed: Apr 28, 2025
1 condition
1 sponsor
17 locations
NCT04592393
Pancreas Cancer Surveillance Using an Abbreviated MRI
NA
Active, not recruiting
200 participants
Started: Oct 28, 2020 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05489250
The PLATON Network
N/A
Active, not recruiting
1,000 participants
Started: Oct 28, 2020 · Completed: May 31, 2032
6 conditions
1 sponsor
31 locations
NCT03837314
Simpler and Safer Deep Brain Stimulation for Parkinson's Disease
NA
Enrolling by invitation
25 participants
Started: Oct 28, 2020 · Completed: Jan 1, 2026
1 condition
2 sponsors
1 location
NCT04767594
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
N/A
Active, not recruiting
1,409 participants
Started: Oct 27, 2020 · Completed: Apr 30, 2029
1 condition
1 sponsor
191 locations
NCT04619069
Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer
PHASE1/PHASE2
Active, not recruiting
60 participants
Started: Oct 27, 2020 · Completed: Oct 31, 2027
1 condition
1 sponsor
1 location
NCT04231877
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
PHASE1
Recruiting
56 participants
Started: Oct 27, 2020 · Completed: Dec 1, 2031
9 conditions
2 sponsors
1 location
NCT04414163
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
PHASE2
Active, not recruiting
23 participants
Started: Oct 27, 2020 · Completed: Feb 28, 2026
2 conditions
1 sponsor
5 locations
NCT04095572
Alternative Prophylaxis in Female Recurrent Urinary Tract Infections
PHASE4
Recruiting
50 participants
Started: Oct 27, 2020 · Completed: Jun 30, 2026
2 conditions
2 sponsors
2 locations
NCT04174105
Gene Transfer Study in Patients With Late Onset Pompe Disease
PHASE1/PHASE2
Active, not recruiting
11 participants
Started: Oct 27, 2020 · Completed: Feb 28, 2030
1 condition
1 sponsor
4 locations
NCT04222413
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
PHASE1
Recruiting
116 participants
Started: Oct 27, 2020 · Completed: Dec 31, 2028
6 conditions
1 sponsor
2 locations
Previous
1
More pages
2000
2001
2002
2003
2004
2005
2006
More pages
2369
Next